Ifp Advisors, Inc Beam Therapeutics Inc. Transaction History

Ifp Advisors, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$36.73 - $51.6 $11,496 - $16,150	-313 Reduced 51.06%	300 $6,000
Q3 2022 Nov 08, 2022	BUY	$39.79 - $70.31 $9,549 - $16,874	240 Added 64.34%	613 $13,000
Q2 2022 Sep 06, 2022	BUY	$29.86 - $62.36 $11,137 - $23,260	373 New	373 $9,000
Q2 2022 Aug 12, 2022	SELL	$29.86 - $62.36 $11,137 - $23,260	-373 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$53.73 - $82.16 $16,871 - $25,798	314 Added 532.2%	373 $21,000
Q1 2022 Aug 08, 2022	BUY	$53.73 - $82.16 $1,504 - $2,300	28 Added 90.32%	59 $3,000
Q4 2021 Jan 12, 2022	BUY	$68.02 - $99.06 $1,156 - $1,684	17 Added 121.43%	31 $2,000
Q3 2021 Oct 06, 2021	BUY	$84.37 - $133.6 $1,181 - $1,870	14 New	14 $2,000
Q2 2021 Jul 13, 2021	BUY	$64.12 - $128.71 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$71.28 - $120.75 $0 - $0	0 New	0 $0

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.